Publication | Closed Access

Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure

HypertensionHeart FailureRenal Hemodynamic EffectsMedicineAntihypertensive TherapyPhysiologyChronic Kidney DiseaseCardiovascular PharmacologyNeuropharmacologyNew AgonistDiuretic ResistanceDopaminePharmacologyCardiologyNephrologyDiastolic FunctionEndocrine Hypertension